Breast fibroadenoma is a common benign tumor of the breast, prevalent in young and middle-aged women between the ages of 20 and 40. It is associated with relatively or absolutely high levels of estrogen in the body, has a malignant rate of about 5%, and is mainly treated by surgical excision. Currently, many people have some ambiguous understanding of breast fibroadenoma: one of them thinks that breast fibroadenoma can be eliminated without surgery by taking medication, and some patients spend a lot of time and financial resources for this. Regarding whether breast fibroadenoma can be eliminated by taking medication, the current consensus in the medical field is that breast fibroadenoma is a kind of disease that cannot be cured by taking medication. Clinically, we do see some breast lumps that disappear after taking medication, and most of these lumps are breast hyperplasia nodules rather than breast fibroadenomas. Secondly, it is believed that breast fibroadenoma is easy to recur after surgery. There is even a popular saying in the society that “it is fine if you don’t cut it, but the more you cut it, the more it will recur”. It is true that there are some cases of post-surgical recurrence, but the recurrence of breast fibroadenoma is not due to surgical stimulation. As a detected breast fibroadenoma, it no longer exists once it is surgically removed. Postoperative tumor recurrence actually consists of two scenarios: either a new tumor develops or a small lesion that existed before surgery gradually grows in size and becomes palpable. Breast fibroadenoma has the characteristic of multiple occurrence and growth, so it is not difficult to understand the so-called “recurrence”. Clinically, there are some measures to reduce postoperative recurrence: firstly, the tumor peritoneum must be removed during the operation, and it is generally required to remove a small amount of normal tissues around the tumor in addition to the tumor body. Secondly, detailed preoperative examination should be performed to remove the existing and potentially resectable tumors at one time so as to avoid residuals. Of course, regular postoperative review should be conducted and tumor recurrence should be treated in time. At present, many new minimally invasive surgical techniques have been applied in clinic, and tumor removal surgery has become simpler and simpler, so patients do not need to have too much concern about surgery. Thirdly, it is believed that breast fibroadenoma is a benign tumor and it does not matter whether it is treated or not. Several issues need to be clarified here: first, without pathological confirmation, it is not certain that the tumor growing in the breast is definitely a benign tumor. Clinically, about 10% of lobular breast cancers have clinical manifestations similar to breast fibroadenomas, and once delayed treatment of breast cancer will bring danger to life. Secondly, under the influence of high estrogen level during pregnancy, breast fibroadenoma grows rapidly and is prone to malignant changes and other negative consequences. In addition to routine gynecological examination before pregnancy, women should also undergo breast examination. If breast tumor is found, it is better to remove it before pregnancy. Thirdly, breast fibroadenoma still has 5% malignancy rate, letting the tumor exist in the body for a long time is not a good idea. Overall, although breast fibroadenoma is a common benign tumor, we shouldn’t be blindly optimistic or fail to deal with it correctly due to various concerns, which may cause the condition to deteriorate. Once detected, it is wise to go to a regular medical institution for treatment.